HomeBusiness NewsU.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

- Advertisement -spot_imgspot_img

Casgevy uses the Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans…

- Advertisement -spot_imgspot_img
Stay Connected
16,985FansLike
4,568FollowersFollow
Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here